AI AutoClassification for eTMF – eCTD

Reduce Manual Processing Time and Costs and Increase Categorization Accuracy with AI AutoClassification for eTMF & eCTD

Are you facing challenges in getting your arms around the vast documentation required for the FDA drug review process? Revolutionize your document processing and regulatory compliance with eTMF autoclassification powered by Court Square Group.

 

Completeness, Quality, & Timeliness: AI AutoClassification for eTMF & eCTD

Despite technology advancements, the clinical documentation process largely remains a human-centric activity. Today, Docxonomy’s intuitive AI technology bridges the gap, automating collection, classification, formatting, and metadata extraction with human-like intelligence. And the results speak for themselves.

Manual Effort Reduction
This solution minimizes manual processing time by 75%, allowing efficient review of classification engine results.

Reduced Costs
Reduce the cost of clinical trial documentation by automating many of the processes.

Improved Accuracy
Reduce human error using AI and Machine Learning (ML) utilizing multiple Large Language Models (LLMs).

Increased Efficiency
Automate many of the manual tasks involved in clinical trial documentation. Free up time to focus on other aspects of the clinical trial process.

Accelerate Decision-Making
Transform large volumes of unstructured documentation into well-organized content in a fraction of the time.

Beneficial Insights
Identify patterns and trends in clinical trial data. Gain new insights into the safety and efficacy of treatments.

Refuse-to-File Actions
In the face of rising regulatory standards, it’s crucial to eliminate misclassifications and missing metadata to avoid RTFs.

Streamline FDA Submissions
Create a unified and organized Electronic Trial Master File (eTMF) to ensure TMF completeness – ensuring more efficient FDA submissions.

 

Core Features of Court Square Group’s AI AutoClassification Solution

  • 21 CFR Part 11 audit trail
  • DIA TMF Reference Model/CDISC standard alignment
  • Built-in quality control checks for high-quality output
  • Document collection and synchronization
  • Unstructured content transformation after completely combining content databases
  • Automatic OCR for content extraction
  • AI capabilities for timely data extraction

Contact Us
First
Last

Dive In

Reduce Manual Processing Time and Increase Accuracy with AI AutoClassification for eTMF & eCTD

 

FAQs about AI AutoClassification

What is AI auto-classification for TMF and eTMF documents?

AI auto-classification uses artificial intelligence and machine learning to automatically identify, categorize, and file clinical trial and regulatory documents into the correct Trial Master File (TMF), electronic Trial Master File (eTMF), or eCTD structure. Instead of manually reviewing and classifying each document, the system analyzes content, assigns metadata, and routes documents to the appropriate location, reducing administrative effort and improving consistency.

How does AI document classification improve clinical trial operations?

AI-powered document classification streamlines the management of large volumes of clinical trial documentation by automating repetitive filing and metadata tasks. This helps teams process documents faster, reduce manual workloads, improve accuracy, and spend more time on higher-value activities such as study oversight, data analysis, and compliance management.

Can AI help reduce TMF filing errors and compliance risks?

Yes. Manual document classification can lead to inconsistent filing, missing metadata, and misplaced documents. AI-assisted classification helps improve accuracy by applying consistent rules and identifying potential errors before documents are finalized. This can support inspection readiness and help reduce the risk of regulatory findings, delays, or Refuse-to-File (RTF) actions.

Does AI auto-classification replace human review?

No. Most life sciences organizations use a “human-in-the-loop” approach where AI performs the initial classification and metadata assignment, while qualified personnel review and approve classifications when needed. This approach combines automation efficiency with human oversight to support quality and regulatory compliance.

What types of documents can be automatically classified?

AI auto-classification can be used for a wide range of clinical and regulatory documents, including TMF documents, eTMF content, regulatory submissions, study reports, correspondence, protocols, informed consent documents, and other content required for clinical trial management and FDA submissions. The system analyzes document content rather than relying solely on file names or manual tagging.

How much time can automated TMF classification save?

Organizations typically see significant reductions in manual processing time because documents are automatically categorized and metadata is assigned during ingestion. By eliminating many manual review and filing steps, teams can process documents more efficiently and focus on exception handling rather than routine classification tasks. Some implementations have reported substantial productivity gains and reduced document-processing effort.

Can AI auto-classification support FDA submissions and regulatory readiness?

Yes. By organizing documents consistently, maintaining accurate metadata, and improving TMF completeness, AI auto-classification can help organizations prepare for regulatory inspections and submissions. A well-organized eTMF or eCTD structure makes it easier to locate required documents, demonstrate compliance, and support faster regulatory review processes.

Is AI document classification secure and suitable for regulated life sciences environments?

AI document classification solutions designed for life sciences are typically implemented within validated, compliant environments that support audit trails, controlled access, and regulatory requirements. Organizations can leverage AI automation while maintaining the security, governance, and documentation standards expected in regulated clinical and regulatory operations.